칸디다 맥락망막염에 합병된 맥락막신생혈관에서 유리체강내 베바시주맙 주입술 치료

초록

Purpose: To report a case of choroidal neovascularization (CNV) secondary to candida chorioretinitis initially treated with an intravitrealbevacizumab injection. Case summary: A 50-year-old female presented at our clinic with decreased vision and metamorphopsia in her left eye of 5 daysduration. She received an anti-fungal treatment 2 months prior due to the presence of endogenous candida choroiditis in botheyes. Fluorescein angiography and optical coherence tomography (OCT) revealed juxtafoveal CNV in her left eye. Three monthlyintravitreal injections of bevacizumab were administered as the initial loading dosage. Her visual symptoms improved andCNV regression was observed on OCT. No recurrence or complications were observed during the 6 month follow-up. Conclusions: Based on the present study results we suggest that intravitreal bevacizumab injection can be used to effectivelytreat CNV and improve visual symptoms during the treatment of juxtafoveal CNV associated with candida choroiditis.

키워드